216 (45865 216)
Gabapentin Capsule
Product Images NDC 45865-216
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This text provides a formula to calculate creatinine clearance (ClCr) which is used to estimate kidney function. It involves multiplying the difference between 140 and the patient's age in years by their weight in kilograms, and then dividing the result by 72 multiplied by their serum creatinine level in mg/dL. For female patients, the final result is further multiplied by 0.85.*
Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)
Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)
Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
This text presents results from controlled post-herpetic neuralgia (PHN) studies, showing the proportion of responders (patients achieving > 50% reduction in pain score) at the endpoint of Study 1 and Study 2. Study 1 had 32% responders while Study 2 had 34% responders. The statistical significance is indicated with p< 0.001. Additionally, the text mentions GBP 3600, PBO, GBP 1800, and GBP 2400, which may refer to different treatment groups or dosages used in the studies.*
Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
